Form 8-K ALBANY MOLECULAR RESEARC For: May 05
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Albany Molecular Research (AMRI) Misses Q1 EPS by 14c
May 10, 2016 7:38 AM EDTAlbany Molecular Research (NASDAQ: AMRI) reported Q1 EPS of $0.07, $0.14 worse than the analyst estimate of $0.21. Revenue for the quarter came in at $102.8 million versus the consensus estimate of $107.2 million.
Albany Molecular Research reaffirmed FY2016 guidance.
For earnings history and earnings-related data on Albany Molecular Research (AMRI) click here.
... More